Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
1.770
-0.020 (-1.12%)
Aug 14, 2025, 11:26 AM - Market open

Mural Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-147.15-128.51-207.45-189.81-175.43
Depreciation & Amortization
3.763.512.571.541.47
Loss (Gain) From Sale of Assets
0.10.1---
Asset Writedown & Restructuring Costs
3.90.92---
Loss (Gain) From Sale of Investments
-1.33-3.6---
Stock-Based Compensation
1.085.0824.1111.9311.5
Change in Accounts Receivable
1.015.5---
Change in Accounts Payable
3.99-2.43-18.258.395.52
Change in Other Net Operating Assets
2.09-9.124.77-0.640.27
Operating Cash Flow
-130.01-128.55-194.25-168.59-156.67
Capital Expenditures
-0.05-0.09-3.45-5.51-4.39
Sale of Property, Plant & Equipment
0.850.07---
Investment in Securities
84.5-25.31---
Investing Cash Flow
85.29-25.33-3.45-5.51-4.39
Issuance of Common Stock
0.220.2---
Other Financing Activities
--468.81174.1161.05
Financing Cash Flow
0.220.2468.81174.1161.05
Net Cash Flow
-44.49-153.68271.11--
Free Cash Flow
-130.06-128.64-197.7-174.1-161.05
Free Cash Flow Per Share
-7.59-7.59-11.85-10.43-
Levered Free Cash Flow
-74.31-82.24-113.89-99.81-
Unlevered Free Cash Flow
-71.99-82.24-113.89-99.81-
Change in Working Capital
7.08-6.05-13.487.755.79
Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q